Avicenna institute synthesizes FITC conjugated antibody

Tehran, March 11, IRNA - Iranian researchers at Avicenna Research Institute have produced fluorescein isothiocyanate (FITC) conjugated antibody. The Headquarters for Development of Stem Cells Technology, affiliated to the Presidential Office's Department of Science and Technology, supported the study. Polyclonal antibodies are secreted by different B cell lineages within the body whereas monoclonal antibodies come from a single cell lineage, Iran Daily reported. They are a collection of immunoglobulin molecules that react against a specific antigen, each identifying a different epitope. FITC is a fluorescein derived reagent having an isothiocyanate functional group attached to the core ring structure. It is one of the most popular reagents for fluorescent labeling of biomolecules and is used mainly in immunoflouresence studies. Avicenna Research Institute (ARI), affiliated to the Academic Center for Education, Culture and Research (ACECR), was established to achieve the latest medical technologies by conducting clinical and laboratory research projects in 1998. The institute consists of three research centers, including Reproductive Biotechnology Research Center, Monoclonal Antibody Research Center and Nanobiotechnology Research Center. The institute also includes the Avicenna Infertility Clinic.